このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Blonder Tongue Laboratories マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Bob Palle

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	1.6yrs
CEOの所有権	16.8%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	14.1yrs

経営陣の近況

Recent updates

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Dec 23

CEO報酬分析

Blonder Tongue Laboratories の収益と比較して、Bob Palle の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Dec 31 2022	US$27k	n/a	-US$3m
Sep 30 2022	n/a	n/a	-US$4m
Jun 30 2022	n/a	n/a	-US$3m
Mar 31 2022	n/a	n/a	-US$656k
Dec 31 2021	US$38k	n/a	US$84k
Sep 30 2021	n/a	n/a	-US$1m
Jun 30 2021	n/a	n/a	-US$3m
Mar 31 2021	n/a	n/a	-US$6m
Dec 31 2020	n/a	n/a	-US$7m
Sep 30 2020	n/a	n/a	-US$9m
Jun 30 2020	n/a	n/a	-US$8m
Mar 31 2020	n/a	n/a	-US$8m
Dec 31 2019	US$534k	US$491k	-US$742k
Sep 30 2019	n/a	n/a	US$2m
Jun 30 2019	n/a	n/a	US$3m
Mar 31 2019	n/a	n/a	US$4m
Dec 31 2018	US$170k	US$60k	-US$1m
Sep 30 2018	n/a	n/a	-US$341k
Jun 30 2018	n/a	n/a	-US$295k
Mar 31 2018	n/a	n/a	-US$191k
Dec 31 2017	US$161k	US$42k	-US$384k

報酬と市場: Bobの総報酬がUS市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Bobの報酬と会社の業績を比較するにはデータが不十分です。

CEO（最高経営責任者

Bob Palle (78 yo)

1.6yrs

在職期間

US$26,542

報酬

Mr. Robert J. Palle, Jr., also known as Bob, has been the Chief Executive Officer and President at Blonder Tongue Laboratories, Inc. since March 17, 2023. Mr. Palle serves as Director of Blonder Tongue Lab...

取締役

名称	ポジション	在職期間	報酬	所有権
Robert Palle	CEO, President & Director	31.1yrs	US$26.54k	16.84% $ 198.0k
Gary Scharmett	Independent Director	26.8yrs	US$26.54k	1.99% $ 23.4k
James Williams	Independent Director	31.1yrs	US$26.54k	1.61% $ 19.0k
Stephen Necessary	Independent Director	6.8yrs	US$26.54k	1.34% $ 15.8k
Steven Shea	Independent Chairman	15.1yrs	US$26.54k	4.51% $ 53.0k
Charles Dietz	Independent Director	13.1yrs	US$26.54k	2.02% $ 23.8k
John Burke	Independent Director	4.8yrs	US$26.54k	0.027% $ 314.8
Michael Hawkey	Independent Director	4.3yrs	US$26.54k	0.076% $ 893.8

14.1yrs

平均在職期間

66.5yo

平均年齢

経験豊富なボード: BDRLの取締役会は経験豊富で経験豊富です ( 13.8年の平均在任期間)。

Blonder Tongue Laboratories マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

Recent updates

Blonder Tongue Announces IP Failover Feature Added to NXG Video Delivery System

Blonder Tongue Laboratories, Inc. Announces the Retirement of Stephen K. Necessary from the Board

Blonder Tongue Laboratories, Inc. Announces President Changes

Blonder Tongue Laboratories, Inc. to Report Q3, 2022 Results on Nov 04, 2022

Blonder Tongue Laboratories Announces Product Standardization with Tier One Broadband Cable Operator

Blonder Tongue Laboratories, Inc. to Report Q2, 2022 Results on Aug 15, 2022

Blonder Tongue Laboratories, Inc.(OTCPK:BDRL) dropped from S&P TMI Index

NYSE American to Suspend Trading Immediately in Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. Announces Furloughing Ronald V. Alterio, the Senior Vice President-Engineering and Chief Technology Officer

Blonder Tongue Laboratories, Inc. Announces Resignation of Anthony Bruno as BOD, Effective from May 25, 2022

Blonder Tongue Laboratories, Inc., Annual General Meeting, May 25, 2022

Blonder Tongue Laboratories, Inc. Announces Retirement of James H. Williams as Member of the Board of Director

NYSE American to Commence Delisting Proceedings Against Blonder Tongue Laboratories

Independent Director Rick Briggs has left the company

Independent Director recently sold US$102k worth of stock

Third quarter 2021 earnings released: US$0.016 loss per share (vs US$0.18 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.14 (vs US$0.12 loss in 2Q 2020)

Director recently sold US$74k worth of stock

First quarter 2021 earnings released: US$0.036 loss per share (vs US$0.21 loss in 1Q 2020)

Full year 2020 earnings released: US$0.76 loss per share (vs US$0.077 loss in FY 2019)

Independent Director recently sold US$77k worth of stock

Blonder Tongue Laboratories, Inc. announced that it has received $0.6 million in funding

New 90-day high: US$1.85

MD of Strategic Accounts & Director recently sold US$52k worth of stock

Have Blonder Tongue Laboratories, Inc. (NYSEMKT:BDR) Insiders Been Selling Their Stock?

Blonder Tongue Laboratories Receives Non-Compliance Letter from NYSE American

New 90-day high: US$1.75

Third quarter 2020 earnings released: US$0.18 loss per share

New 90-day high: US$1.50

NYSE Accepts Compliance Plan of Blonder Tongue Laboratories, Inc

New 90-day high - US$1.35

Earnings released

Blonder Tongue Laboratories, Inc. to Report Q2, 2020 Results on Aug 07, 2020